Xortx stock surges 60% as potential kidney disease drug shows promise in early stage study

Xortx Therapeutics (XRTXF) (XRTX) reported data from a bridging pharmacokinetics trial of its proprietary formulation of oral oxypurinol, Xorlo being explored for kidney disease.The...

Related Keywords

Allen Davidoff ,Medicine Research Laboratory ,Diverse Team Of Multi ,Modern Medicine Research Laboratory ,Diverse Team ,Multi Ethnic Young Scientists Passes Samples ,Advanced Lab ,High Tech Equipment ,Microbiology Researchers Design ,Develop Drugs ,